Skip to main content
. 2021 Nov 5;322(1):H25–H35. doi: 10.1152/ajpheart.00449.2021

Table 1.

Participant demographics

  Normal Weight Obese P Value
n 36 22
%Female (male/female) 53 (17/19) 68 (7/15) 0.248
Age, yr 26 ± 6 29 ± 6 0.115
Height, cm 171 ± 8 170 ± 10 0.606
Weight, kg 64 ± 8 106 ± 19 <0.001
Waist circumference, cm 77 ± 7 111 ± 14 <0.001
Body mass index, kg/m2 22 ± 2 36 ± 5 <0.001
Body fat, % 26 ± 9 47 ± 7 <0.001
Lean forearm mass, g 760 ± 208 877 ± 272 0.128
Glucose, mg/dL 68 ± 8 71 ± 7 0.068
Insulin, μIU/mL 8.7 ± 2.9 16.0 ± 4.2 <0.001
HOMA-IR 1.5 ± 0.5 2.9 ± 0.6 <0.001
Total cholesterol, mg/dL 150 ± 23 156 ± 22 0.314
Systolic blood pressure, mmHg 110 ± 6 123 ± 6 <0.001
Diastolic blood pressure, mmHg 66 ± 7 73 ± 7 <0.001
Forearm blood flow, mL/min/100 g 6.2 ± 2.8 8.1 ± 4.5 0.078
Forearm vascular conductance, mL/min/100 g/100 mmHg 7.5 ± 3.2 9.2 ± 5.6 0.461

Values are means ± SD. Body fat and waist circumference (n = 35 normal weight). Insulin and homeostatic model assessment for insulin resistance (HOMA-IR; n = 19 normal weight; n = 11 obese). %Female compared using χ2 test. All other variables compared using one-way analysis of variance or Kruskal–Wallis one-way analysis of variance on ranks (normality, Shapiro–Wilk; equal variance, Brown–Forsythe).